| Contents: |
Copyright; Dedication; Preface; Contributors; Reviewer List; Acknowledgements; Brief Contents; Detailed Contents; Part 1: Introduction to Pharmacology; Chapter 1: Historical and Legal Issues; History of Drugs and Pharmacy; Legal Foundations; United States Food and Drug Administration; Over-the-Counter Products; Naming of a Drug; Generic and Brand-Name Drug Ingredients; Medical Abbreviations; Drug Information; Pharmacists; Poison Control Centers; Reference Books; Pharmacy in Athletic Training; Chapter 2: Pharmacokinetics and Pharmacodynamics; What Is a Drug?; Pharmacodynamics; Receptor Sites. Dose ResponseTime Response; Therapeutic Index; Plasma Dose Response; Half-Life; Pharmacokinetics; Absorption; Enteral; Parenteral; Inhalation; Topical; Distribution; Metabolism; Excretion; Factors Affecting Drug Response; Barriers to Drug Distribution; Drug Safety; Part 2: Prescription and Over-the-Counter Drugs; Chapter 3: Anti-inflammatory Medications; The Inflammatory Response; Eicosanoids; Leukotrienes; Prostaglandins; Mediation of Inflammatory Process; Fever Mediation; Gastric Protection; Reproductive System; Renal Blood Flow; Hemostasis; Pulmonary Effects; Anti-Inflammatory Medications. AspirinEffects of Aspirin; Reye's Syndrome; Aspirin-Sensitive Asthma; Acetaminophen; NSAIDs; COX-2 Inhibitors; Topical NSAIDs; Overview of Selected NSAIDs; Ibuprofen (Advil, Motrin, Nuprin); Naproxen (Naprosyn, Aleve); Indomethacin (Indocin); Phenylbutazone; Nabumetone (Relafen); Rofecoxib (Vioxx); Ketorolac (Toradol); NSAID Indications; Adverse Effects; Drug Interactions; Glucocorticosteroids; History; Physiology of Adrenal Corticosteroids; Current Use of Corticosteroids in Sports Medicine; Adverse Effects; Chapter 4: Skeletal Muscle-Relaxant Drugs; Muscle Spasm and Spasticity. Malignant HyperthermiaMuscle-Relaxant Drugs; Spasms; Spasticity; Adverse Effects; Chapter 5: Drugs for Diabetes Mellitus; Definition of Diabetes; Glucose Metabolism; Type 1 Diabetes Mellitus; Type 2 Diabetes Mellitus; Management of Diabetes; Glucose Monitoring; Diet and Exercise; Insulin Administration; Insulin Injection Devices; Insulin Types; Rapid-acting Insulin; Insulin Lispro (Humalog); Insulin Aspart (Novolog); Short-acting Insulin; Regular; Intermediate-acting Insulin; Isophane Insulin (NPH) and Insulin Zinc (Lente); Long-acting Insulin; Insulin Zinc Extended (Ultralente). Insulin Glargine (Lantus)Combination Insulin Products; Insulin Therapy; Insulin Therapy Adverse Effects; Hypoglycemia; Diabetic Ketoacidosis; Lipohypertrophy; Lipoatrophy; Local Skin Reactions; Oral Antidiabetic Agents; Alpha-Glucosidase Inhibitors; Biguanides; Meglitinides; Thiazolidinediones; Sulfonylureas; The Athletic Trainer's Responsibility; Chapter 6: Drugs for Cardiovascular Arrhythmias and Hypertension; Arrhythmias; Class I; Class II; Class III; Class IV; Adverse Effects; Antiarrhythmic Drug Interactions; Device Therapy; Hypertension; Medications for Hypertension; Adverse Effects. |
Finding libraries that hold this item...
Cite/Export
eBook : Document : EnglishView all editions and formats
